JG
PTLA

Joel Greenblatt’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Joel Greenblatt’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-26,110
Closed -$624K – 1277
2019
Q4 		$624K Sell
26,110
-53,193
-67% -$1.47M 0.01% 736
2019
Q3 		$2.13M Buy
+79,303
New +$2.23M 0.04% 445
2019
Q2 		– Sell
-8,209
Closed -$285K – 1344
2019
Q1 		$285K Buy
+8,209
New +$237K ﹤0.01% 1007
2017
Q3 		– Sell
-23,898
Closed -$1.34M – 1089
2017
Q2 		$1.34M Sell
23,898
-3,812
-14% -$153K 0.02% 591
2017
Q1 		$1.09M Buy
+27,710
New +$883K 0.01% 650

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return

Joel Greenblatt's PTLA Position: Q1 2020 in Review

Joel Greenblatt sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2020, closing a stake of 26,110 shares — an estimated $624K sold.

Joel Greenblatt first reported a position in PTLA in Q1 2017 and held it in 5 quarters. The position peaked at $2.13M in Q3 2019. 187 funds tracked by Wall St. Rank hold PTLA as of Q1 2020.

  • Joel Greenblatt reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
  • Joel Greenblatt sold 26,110 Portola Pharmaceuticals, Inc. shares in Q1 2020, an estimated $624K.
  • Joel Greenblatt first reported a position in Portola Pharmaceuticals, Inc. in Q1 2017 and held it in 5 quarters.
  • Joel Greenblatt's Portola Pharmaceuticals, Inc. position peaked at $2.13M in Q3 2019.
  • 187 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2020.

Based on Gotham Asset Management's 13F filing for Q1 2020, filed 15 May 2020.